Chronic Obstructive Pulmonary Disease Endpoints Study

Completed · Phase 4

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

This study will last for approximately 14 weeks and will involve 5 visits. The study is being carried out to look at different ways of measuring the effect of drug treatment on COPD. COPD is a respiratory disease which can affect your breathing and daily life. Symptoms of COPD can include breathlessness, cough, and wheeze. COPD varies enormously from patient to patient. The effects of drug treatment are usually measured by conducting lung function tests (breathing tests) using a machine called a spirometer but this does not always provide a complete picture of how well your COPD is responding. In this study we therefore want to look at new and more sensitive ways of measuring COPD. The results of this research will help in the assessment of new drugs for COPD in the future.

Key facts

Study ID

NCT00358358

Run by

GlaxoSmithKline

People needed

163

Starts

2006-03-01

Expected to finish

2007-02-01

Last updated by the study team

2017-01-20

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of COPD
• Current or ex-smoker at least 10 pack- years

You may not qualify if…

• Diagnosis of asthma
• Active respiratory disorder other than COPD
• Evidence of clinically significant uncontrolled non-pulmonary disease
• Carcinoma not in complete remission for last 5 years
• Lung volume reduction surgery in previous 12 months
• Nocturnal positive pressure for sleep apnea
• Other inclusion and exclusion criteria will be evaluated at the first study visit.

Where it is running

• GSK Investigational Site — Absecon, New Jersey, United States
• GSK Investigational Site — Charleston, South Carolina, United States
• GSK Investigational Site — Greenville, South Carolina, United States
• GSK Investigational Site — Spartanburg, South Carolina, United States
• GSK Investigational Site — Santiago, Región Metro de Santiago, Chile
• GSK Investigational Site — Valparaíso, Valparaiso, Chile
• GSK Investigational Site — Tartu, Estonia
• GSK Investigational Site — Barnaul, Russia
• GSK Investigational Site — Moscow, Russia
• GSK Investigational Site — Moscow, Russia
• GSK Investigational Site — Nizhnekamsk, Russia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.